Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme

Journal of Medical Screening

Volumn 11, Issue 2, 2004, Pages 65-69

  Richardson, A ^a   Graham, P ^a   Brown, T ^b   Smale, P ^b   Cox, B ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CALCULATION; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PREVALENCE; REGISTRATION; STANDARDIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; MASS SCREENING; NEW ZEALAND; PREVALENCE; REGISTRIES; TIME FACTORS;

EID: 3042609779     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/096914104774061038     Document Type: Article

References (19)

1. Skegg DCG, Paul C, Benson-Cooper D, et al. Mammographic screening for breast cancer: prospects for New Zealand. NZ Med J 1988;101:531-3.
2. European Commission. European Guidelines for Quality Assurance in Mammography Screening, 3rd edn. Luxembourg: European Community, 2001.
3. Blanks RG, Day NE, Moss SM. Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate. J Med Screen 1996;3:79-81.
4. Tabár L, Fagerberg GCJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
5. Tabár L, Fagerberg G, Duffy SW, et al. Update of the Swedish two county program of mammographic screening for breast cancer. Radiol Clin N Am 1992;30:187-210.
6. Cancer Registration Working Group. Cancer Registration in New Zealand. Wellington: Department of Statistics, 1988.
7. New Zealand Health Information Service. Cancer: New Registrations and Deaths 1996. Wellington: Ministry of Health, 2000.
8. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. London: Chapman and Hall, 1995.
9. Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-8.
10. Hodgen E, Tobias M, Cheung J. Cancer in New Zealand: Trends and Projections. Public Health Intelligence Occasional Bulletin No. 15. Wellington, NZ: Ministry of Health, 2002.
11. Blanks RG, Moss SM, Patnick J. Results from the UK NHS breast screening programme 1994-1999. J Med Screen 2000;7:195-8.
12. Richardson A, Wells JE. Breast cancer screening: the effect of self-selection for screening on comparisons of randomised controlled trials. J Med Screen 1997;4:16-8.
13. Threlfall AG, Woodman CBJ. Risk of breast cancer in women who attend the NHS breast screening programme: cohort study. BMJ 2001;323:140.
14. Osmond C. Using age, period and cohort models to estimate future mortality rates. Int J Epidemiol 1985;14:124-9.
15. Holford T. The estimation of age, period and cohort effects for vital rates. Biometrics 1983;39:311-24.
16. Robertson C, Boyle P. Age-period-cohort analysis of chronic disease rates. I: modelling approach. Statistics Med 1998;17:1305-23.
17. Berzuini C, Clayton D. Bayesian analysis of survival on multiple time scales. Statistics Med 1994;13:823-38.
18. Dyba T, Hakulinen T, Paivarinta A. A simple non-linear model in incidence prediction. Statistics Med 1997;16:2297-309.
19. Kass RE, Raferty A. Bayes Factors. J Am Stat Ass 1995;90:773-95.